<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="publisher-id">JOACP</journal-id><journal-id journal-id-type="publisher-id">J Anaesthesiol Clin Pharmacol</journal-id><journal-title-group><journal-title>Journal of Anaesthesiology, Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0970-9185</issn><issn pub-type="epub">2231-2730</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9438824</article-id><article-id pub-id-type="publisher-id">JOACP-38-13</article-id><article-id pub-id-type="doi">10.4103/joacp.joacp_550_21</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Anesthesia management in a post Covid-19 obstetric patient-What we need to know</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bajwa</surname><given-names>Sukhminder J. S.</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Ridhima</given-names></name><xref rid="aff2" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Kurdi</surname><given-names>Madhuri S.</given-names></name><xref rid="aff3" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Katikar</surname><given-names>Manisha</given-names></name><xref rid="aff4" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Bajwa</surname><given-names>Sukhwinder K.</given-names></name><xref rid="aff5" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Choudhary</surname><given-names>Ripon</given-names></name><xref rid="aff6" ref-type="aff">5</xref></contrib></contrib-group><aff id="aff1">Department of Anesthesiology and Intensive Care, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab, India</aff><aff id="aff2"><label>1</label>Department of Anesthesia and Critical Care, Maulana Azad Medical College (MAMC), Delhi, India</aff><aff id="aff3"><label>2</label>Department of Anesthesiology, Karnataka Institute of Medical Sciences (KIMS), Hubballi, Karnataka, India</aff><aff id="aff4"><label>3</label>Department of Anesthesia, Ashwini Rural Medical College, Solapur, India</aff><aff id="aff5"><label>4</label>Department of Obstetrics and Gynecology, Bajwa Maternity and Nursing Home, Patiala, Punjab, India</aff><aff id="aff6"><label>5</label>Department of Anesthesia and Intensive Care, Govind Ballabh Pant Hospital, New Delhi, India</aff><author-notes><corresp id="cor1">
<bold>Address for correspondence:</bold> Dr. Ridhima Sharma, Department of Anesthesia and Critical Care, Maulana Azad Medical College (MAMC), Delhi, Pin Code 110002 , India. E-mail: <email xlink:href="drridhimasharma@yahoo.com">drridhimasharma@yahoo.com</email>
</corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>30</day><month>6</month><year>2022</year></pub-date><volume>38</volume><issue>Suppl 1</issue><fpage>S13</fpage><lpage>S21</lpage><history><date date-type="received"><day>22</day><month>12</month><year>2021</year></date><date date-type="rev-recd"><day>25</day><month>3</month><year>2022</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2022</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2022 Journal of Anaesthesiology Clinical Pharmacology</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><p>The outbreak of the coronavirus disease (COVID)-19 pandemic has led to unprecedented challenges globally. At the outset of the receding second wave and third wave of COVID-19, many patients who have recovered from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are coming for elective/emergency surgery. This demands a noteworthy emphasis on the post-COVID-19 obstetric patients. The administration of quality and safe obstetric anesthesia are quite challenging in this mentioned subset due to the overlap of signs and symptoms of COVID-19 with the constitutional signs and symptoms of pregnancy. The physiological changes in normal pregnancy and vascular, metabolic alterations in high-risk pregnancy may affect or exacerbate the pathogenesis or clinical presentation of COVID-19, respectively. This article highlights the specific concerns in recovered COVID-19 pregnant patients with associated comorbidity posted for surgery and their repercussions on anesthesia management.</p></abstract><kwd-group><kwd>Anesthesia</kwd><kwd>neonate</kwd><kwd>obstetric</kwd><kwd>post-COVID</kwd><kwd>pregnancy</kwd><kwd>SARS-CoV-2</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The severe acute respiratory syndrome coronavirus (SARS-CoV)-2 pandemic has presented unprecedented challenges globally.[<xref rid="R1" ref-type="bibr">1</xref>] The viral infection presents with a constellation of symptoms varying from a mild flu-like illness to life-threatening pneumonia picture. No age group is immune to this deadly infection. Furthermore, as the pandemic is raging on, there is a shift of paradigm from the existing scenario of coronavirus disease (COVID)-19, as more patients are COVID-19 &#x0201c;recovered&#x0201d;. Globally, 210 million women become pregnant every year and give birth to 130 million babies. Obstetric patients are specifically vulnerable to severe pneumonia due to alteration in the immune and physiological response; increased oxygen consumption, decreased functional residual capacity (FRC), decreased chest compliance, and altered T-lymphocyte immunity, overall contribute to increased maternal mortality and morbidity.[<xref rid="R2" ref-type="bibr">2</xref>] Noteworthy, pregnancy is a state of partial immune response which makes this particular cohort prone to viral infection. Therefore, post-COVID-19 pregnant patients may have a serious post-viral sequel. Nevertheless, it has been reported that age and other underlying medical conditions can increase the severity of the COVID-19 illness both during and for 42 days following delivery.[<xref rid="R3" ref-type="bibr">3</xref>] The post-COVID-19 era has given birth to various myths and fallacies regarding medical, surgical, and obstetrical procedures. In the coming time, we may rendezvous with a large number of post-COVID obstetric patients requiring operative interventions. Anesthesia concerns in this vulnerable cohort will be challenging compared to non-COVID obstetric patients. At present, there exist no concrete guidelines for the anesthetic management of this subset although a few suggested guidelines and advisories are available. The current clinical evidence suggests that pregnant patients with COVID-19 infection having associated pneumonia have an increased menace of obstetric complications; cesarean section, premature rupture of membranes, preeclampsia, and preterm labor.[<xref rid="R4" ref-type="bibr">4</xref><xref rid="R5" ref-type="bibr">5</xref>] The World Health Organization (WHO) has also stated that pregnant patient with pre-existing comorbidities including obesity, diabetes, heart disease, and hypertension may have the additional risk of developing severe COVID-19.[<xref rid="R6" ref-type="bibr">6</xref>] Thus, obstetric anesthesiologists may encounter recovered COVID-positive patients for elective/emergency surgical procedures that may pose unique unaccustomed challenges. The present review aims to increase the insight into peri-intraoperative anesthesia concerns, the effect of post-viral infection on different organs in pregnancy, the associated comorbidities, and postoperative management of post-COVID-19 patients.</p></sec><sec><title>Methodology</title><p>Keeping this research question in mind, we did a literature search using the keywords COVID-19, SARS-CoV2, SARS-CoV-1, pregnancy, obstetric, neonate, anesthesia management, and related terms in the medical databases including Google Scholar, MedARXiv, PubMed, Cochrane, and Web of Science. In addition to these, references were spotted through a manual search of bibliographies and via the citations in the articles. Specific concerns in recovered COVID-19 pregnant patients and the associated comorbidity posted for surgery, and their repercussions on anesthesia management are discussed extensively in this review.</p><sec><title>Pathophysiology of COVID-19 and its implications in pregnancy</title><p>COVID-19 is a single-stranded capsulated ribonucleic acid (RNA) virus.[<xref rid="R7" ref-type="bibr">7</xref>] The immunological response to COVID-19 depends on the function of the immune system.[<xref rid="R7" ref-type="bibr">7</xref>] The modulations in immune response to allow growth of the allogeneic fetus during pregnancy may result in an altered immune response to infection.[<xref rid="R8" ref-type="bibr">8</xref><xref rid="R9" ref-type="bibr">9</xref>] SARS-CoV-2 enters the body and infects the respiratory system mainly via two mechanisms. First, there is a direct attachment of the angiotensin-converting enzyme 2 (ACE2) to spike protein and release of the nucleocapsid protein and viral genome into the cell cytoplasm of the host.[<xref rid="R10" ref-type="bibr">10</xref>] Second, the alternative avenue is the direct plasma membrane route through transmembrane serine protease 2 (TMPRSS2), causing proteolytic cleavage of the spike protein and fusion with the cell membrane.[<xref rid="R11" ref-type="bibr">11</xref>] During pregnancy, there is upregulation of ACE 2 and renin-angiotensin-aldosterone system (RAAS). Furthermore, this normal hormonal profile in pregnancy favors SARS-CoV-2 entry, and raises the possibility of the increased risk of the pregnant patient acquiring this infection. The viral binding to ACE2 causes its downregulation and un-proportionate increase in angiotensin-2 (Ang) relative to Ang (1-7), thereby, aiding vasoconstriction, preeclampsia, preterm labor, and fetal growth retardation [<xref rid="joacp_550_21-f001" ref-type="fig">Figure 1</xref>].[<xref rid="R12" ref-type="bibr">12</xref><xref rid="R13" ref-type="bibr">13</xref>]</p><fig position="float" id="joacp_550_21-f001"><label>Figure 1</label><caption><p>Pathophysiology of COVID-19 and its implication on pregnancy</p></caption><graphic xlink:href="JOACP-38-13-g001" position="float"/></fig></sec><sec><title>The interplay of post-COVID-19 infection on physiological changes in pregnancy and its effects on different organs</title><p>Normal physiological alterations in pregnancy are considered essential for the development of the fetus, to increase the metabolic demand of the body, and for childbirth. These amendments start from the first trimester to labor, peak at term and return to the pre-pregnancy level after delivery in the postpartum period.[<xref rid="R14" ref-type="bibr">14</xref>] Although these changes are well tolerated in a normal healthy pregnant patient, these can be magnified in the presence of COVID-19-related pathophysiological changes. Comprehensive knowledge of the physiological changes concerning post-COVID-19 infection is considered crucial for the successful management of obstetric patients. This conceptual understanding will further assist the anesthesiologists to tailor the anesthetic technique to manage the post-COVID-19 patients and critically ill pregnant patients with comorbidity.</p></sec><sec><title>Respiratory system</title><p>Recent evidence has revealed that the lung is the most affected organ in COVID-19, and its pathogenesis includes capillary disruption, hyaline membrane formation, alveolar proliferation (fibrous), alveolar epithelium disruption, and pulmonary consolidation.[<xref rid="R15" ref-type="bibr">15</xref><xref rid="R16" ref-type="bibr">16</xref>]</p><p>Furthermore, pregnancy is a restrictive lung disease and various studies have inferred damaged lung in the post-COVID-19 recovered patient from SARS-CoV-2 pneumonia, leading to a restrictive lung pattern persisting up to 6 weeks post-recovery, thereby, causing an exponentially increased risk of life-threatening comorbidities.[<xref rid="R17" ref-type="bibr">17</xref><xref rid="R18" ref-type="bibr">18</xref>] The diffusing capacity for carbon monoxide (<italic toggle="yes">D</italic><sub>LCO</sub>) was the most common abnormality followed by impaired total lung capacity (TLC), ranging from 15.5 to 43.6% and 5.2 to 10.9%, respectively, and a decline in the 6-min walk distance (6-MWD), indicating impaired intra-alveolar diffusion capacity.[<xref rid="R19" ref-type="bibr">19</xref><xref rid="R20" ref-type="bibr">20</xref><xref rid="R21" ref-type="bibr">21</xref>] Furthermore, forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), TLC, increased ratio of FEV1/FVC, and DLCO were significantly lower in the patients after severe/critical COVID-19 [<xref rid="joacp_550_21-t001" ref-type="table">Table 1</xref>].[<xref rid="R22" ref-type="bibr">22</xref>]</p><table-wrap position="float" id="joacp_550_21-t001"><label>Table 1</label><caption><p>Alteration of physiological changes in normal pregnancy in the post-COVID-19 pregnant patient</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="left" rowspan="1" colspan="1">Change in normal Pregnancy</th><th align="left" rowspan="1" colspan="1">Alteration in post-COVID Pregnant patient</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ERV</td><td align="left" rowspan="1" colspan="1">Decreased</td><td align="left" rowspan="1" colspan="1">Decreased</td></tr><tr><td align="left" rowspan="1" colspan="1">FRC</td><td align="left" rowspan="1" colspan="1">Decreased</td><td align="left" rowspan="1" colspan="1">Decreased</td></tr><tr><td align="left" rowspan="1" colspan="1">VC</td><td align="left" rowspan="1" colspan="1">No change</td><td align="left" rowspan="1" colspan="1">Decreased</td></tr><tr><td align="left" rowspan="1" colspan="1">TLC</td><td align="left" rowspan="1" colspan="1">Decreased</td><td align="left" rowspan="1" colspan="1">Decreased</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV<sub>1</sub></td><td align="left" rowspan="1" colspan="1">No change</td><td align="left" rowspan="1" colspan="1">Decreased</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV<sub>1</sub>/FVC</td><td align="left" rowspan="1" colspan="1">No change</td><td align="left" rowspan="1" colspan="1">Increased</td></tr><tr><td align="left" rowspan="1" colspan="1">IRV</td><td align="left" rowspan="1" colspan="1">Increased</td><td align="left" rowspan="1" colspan="1">Decreased</td></tr><tr><td align="left" rowspan="1" colspan="1">IC</td><td align="left" rowspan="1" colspan="1">Increased</td><td align="left" rowspan="1" colspan="1">Decreased</td></tr><tr><td align="left" rowspan="1" colspan="1">DLCO</td><td align="left" rowspan="1" colspan="1">Increased</td><td align="left" rowspan="1" colspan="1">Decreased</td></tr></tbody></table><table-wrap-foot><fn><p>ERV: Expiratory reserve volume, FEV1: Forced expiratory volume in 1 s; FVC: Forced vital capacity; TLC: Total lung capacity, FRC: Functional residual capacity, VC: Vital capacity, IRV: Inspiratory reserve volume, IC: Inspiratory capacity, DLCO: Diffusing capacity of the lung for carbon monoxide</p></fn></table-wrap-foot></table-wrap><p>In conclusion, impaired respiratory muscle strength, decreased diffusion capacity, lung imaging abnormalities, decreased FRC, and decreased ability to clear pulmonary secretions postoperatively can be found in COVID-19 recovered patients.[<xref rid="R23" ref-type="bibr">23</xref>] Despite adequate preoxygenation, increased oxygen consumption and decreased FRC may lead to rapid desaturation during apnea.[<xref rid="R24" ref-type="bibr">24</xref>] Apart from the post-viral residual component, there can be an exacerbation of pre-existing pulmonary complications, thereby, necessitating preoperative optimization and a thorough evaluation. As per a recent recommendation, a 6-week respiratory rehabilitation can improve lung functions effectively.[<xref rid="R25" ref-type="bibr">25</xref>]</p></sec><sec><title>Cardiovascular system (CVS)</title><p>A high prevalence of cardiovascular disease has been observed in COVID-19 illness.[<xref rid="R26" ref-type="bibr">26</xref>] Takotsubo cardiomyopathy, a stress-induced secondary cardiomyopathy, is common in COVID-19 due to pneumonia.[<xref rid="R27" ref-type="bibr">27</xref>] Perioperative complications may occur due to increased cardiac demand, decreased systemic oxygenation due to pneumonia, and concurrent electrolyte imbalance or immune dysregulation. Factors enhancing the imbalance between the myocardial oxygen demand (hypoxia, hypercarbia, hyperglycemia, and acidosis) should be avoided intraoperatively.</p><p>Alteration in the aortocaval compression compensatory mechanism may be observed in post-SARS-CoV-2 infection due to variation in the renin-angiotensin system to maintain blood pressure in the supine position, which may result in supine hypotension syndrome characterized by pallor, transient tachycardia followed by bradycardia, sweating, hypotension, and malaise.[<xref rid="R28" ref-type="bibr">28</xref><xref rid="R29" ref-type="bibr">29</xref>] Therefore, the pregnant patient should be preferably placed laterally with a wedge under the right buttock.</p><p>There is shortness of breath in 18% of the COVID-19 recovered patients.[<xref rid="R30" ref-type="bibr">30</xref>] Moreover, there also exists physiological dyspnea due to increased maternal oxygen requirement, fetal oxygen consumption, and gestational anemia. Therefore, it should be distinguished from pathological breathlessness.[<xref rid="R31" ref-type="bibr">31</xref>] There can be other related changes in the CVS in post-COVID-19 pregnant patients [<xref rid="joacp_550_21-t002" ref-type="table">Table 2</xref>].</p><table-wrap position="float" id="joacp_550_21-t002"><label>Table 2</label><caption><p>Cardiovascular post-COVID-19 manifestations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Post-COVID-19 Cardiovascular manifestations</th><th align="left" rowspan="1" colspan="1">Normal Physiological Cardiovascular manifestations in an obstetric patient</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Asymptomatic cardiac arrhythmias <break/>Increased risk of left ventricular diastolic/systolic dysfunction <break/>Pulmonary arterial hypertension, heart failure, fresh myocardial infarction <break/>Arrhythmias, including premature ventricular complexes, ventricular tachyarrhythmias, and atrial fibrillation due to healing myocarditis and myocardial fibrosis <break/>Inappropriate sinus tachycardia or bradycardia <break/>Elevated serum cardiac troponin levels <break/>Abnormalities in cardiac imaging</td><td align="left" rowspan="1" colspan="1">Sinus tachycardia <break/>Non-sustained arrhythmia, palpitations, and missed beats <break/>Increased stroke volume (20-30%) <break/>Increased cardiac output and heart rate (15-25%) <break/>Increased blood volume (20%) <break/>Wide pulse pressure <break/>Reduced mean arterial pressure, leading to sodium and water retention and increased plasma volume (40-50%) <break/>Increased left ventricular end-diastolic volume <break/>Increased ejection fraction <break/>Elevated serum cardiac troponin levels in hypertension and preeclampsia <break/>The cardiac silhouette may appear more "horizontal"</td></tr></tbody></table></table-wrap></sec><sec><title>Immune response</title><p>
<list list-type="bullet"><list-item><p>The modulations in maternal immune response favor T-helper 2 (Th-2; anti-inflammatory, interleukin (IL)-4,10,13, and transforming growth factor-&#x003b2; (TGF-&#x003b2;) than Th-1 (proinflammatory, microbicidal, interferon-&#x003b3; (IFN-&#x003b3;), IL1&#x003b1;, IL-1&#x003b2;, IL-6, and IL-12).[<xref rid="R32" ref-type="bibr">32</xref>]</p></list-item><list-item><p>The COVID-19 patients have both Th-1 and Th-2 activation; IFN-&#x003b3;, IL-&#x003b2;, IL-4,10, and predominantly IL-6, and overall contribute to high mortality.[<xref rid="R33" ref-type="bibr">33</xref><xref rid="R34" ref-type="bibr">34</xref>]</p></list-item><list-item><p>Although there is a dearth of data on the immune response of SARS-CoV-2 in pregnant patients, the available evidence suggests that overall, pregnancy increases the risk of infection and mortality compared to non-pregnant patients.[<xref rid="R35" ref-type="bibr">35</xref>]</p></list-item><list-item><p>It is imperative to know the timing of acquiring the COVID-19 infection. The first and third trimesters are considered proinflammatory. Noteworthy, the SARS-CoV-2 infection acquired during this time has an exaggerated response to the virus, and thus, the patient may land up in a cytokine storm, thus, increasing the morbidity and mortality in the parturient.[<xref rid="R36" ref-type="bibr">36</xref>]</p></list-item><list-item><p>Clinical evidence has suggested that post-COVID-19 parturients with mild residual symptoms may need intensive care unit admission for respiratory symptoms.[<xref rid="R37" ref-type="bibr">37</xref><xref rid="R38" ref-type="bibr">38</xref>]</p></list-item><list-item><p>Lastly, there is a high level of stress and inflammation at the level of labor, further enhancing the poor outcome in post-COVID-19 recovered patients.[<xref rid="R39" ref-type="bibr">39</xref>]</p></list-item></list>
</p></sec><sec><title>Thrombo-embolic phenomenon</title><p>The net result of the post-COVID-19 changes and physiological changes in pregnancy is a hypercoagulable state [<xref rid="joacp_550_21-t003" ref-type="table">Table 3</xref>].[<xref rid="R23" ref-type="bibr">23</xref>]</p><table-wrap position="float" id="joacp_550_21-t003"><label>Table 3</label><caption><p>Comparison of coagulation changes between the post-COVID pregnant patient and normal pregnancy</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Changes in post-COVID pregnant patient</th><th align="left" rowspan="1" colspan="1">Changes in normal pregnancy</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Hypercoagulable state <break/>Thrombotic events <break/>Mild thrombocytopenia <break/>Prolongation of prothrombin time (PT), International normalized ratio (INR), and Thrombin time (TT) <break/>Decreased activated partial thromboplastin time (aPTT). <break/>Increased D-dimer</td><td align="left" rowspan="1" colspan="1">Hypercoagulable state <break/>Increased risk of the thrombo-embolic phenomenon <break/>Mild thrombocytopenia <break/>Shortened PT <break/>INR normal or slight decrease <break/>Shortened TT <break/>No change or slight decrease aPTT <break/>Increased D-dimer (up to 400%)</td></tr></tbody></table></table-wrap></sec><sec><title>Endocrine system</title><p>SARS-CoV-2 enters the pancreas through the ACE2 receptors expressed in the endocrine pancreas. About 51% of the post-COVID-19 recovered patients may develop new-onset diabetes with no history of diabetes or receiving any steroid treatment during the illness.[<xref rid="R40" ref-type="bibr">40</xref>] Overall, metabolic and hormonal perturbations caused by the involvement of the pancreas, thyroid, and adrenal gland have been noted. The post-COVID-19 trajectory consists of mainly primary hypothyroidism, hypothalamic-pituitary-adrenal axis damage, hypocortisolism, and secondary hypothyroidism.[<xref rid="R23" ref-type="bibr">23</xref>]</p></sec><sec><title>Neurological system</title><p>Cerebrovascular accidents are common neurological sequelae in post-COVID-19 patients. There can be a residual neuromuscular weakness, or headache (2&#x02013;3% post-COVID), that may lead to an excruciating spinal headache. Critical illness myopathy, fatigue, and muscle weakness can be observed in the recovering parturient and should be considered before employing regional anesthesia and perioperative risk stratification.</p></sec><sec><title>Renal system</title><p>Acute kidney injury (AKI) after SARS-CoV-2 infection has proved to be an important risk factor for predicting mortality in critically ill patients. Due to AKI, approximately 35% of the patients recovered from SARS-CoV-2 may have a decreased glomerular filtration rate (GFR) for up to 6 months.[<xref rid="R41" ref-type="bibr">41</xref>] Also, in the perioperative period, further insults like hypovolemia due to blood loss, improper fluid management, hypotension, and use of nephrotoxic drugs can exacerbate kidney injury.[<xref rid="R23" ref-type="bibr">23</xref>] The aforementioned causes may increase the risk of intraoperative AKI and due precautions should be taken to prevent further injury.</p></sec><sec><title>Gastrointestinal (GI) system</title><p>The most cardinal gastrointestinal symptoms in the post-COVID-19 state are lack of appetite, nausea, and vomiting.[<xref rid="R42" ref-type="bibr">42</xref>] All this can lead to Mendelson&#x02019;s syndrome; a well-recognized cause of lung injury and pulmonary edema, secondary to aspiration of gastric contents in the tracheobronchial tree.[<xref rid="R43" ref-type="bibr">43</xref>]</p></sec><sec><title>Preoperative considerations</title><p>
<list list-type="bullet"><list-item><p>Anesthesia implications will be profound in the indexed subset, as the normal physiology of such patients will be impacted both by changes due to pregnancy and COVID-19 post-infection. Therefore, a thorough detailed preoperative evaluation is paramount.</p></list-item><list-item><p>The preoperative evaluation, history taking, functional status before surgery, and consent particularly to COVID-19 status should be given utmost importance.</p></list-item><list-item><p>Risk stratification should be done in the preoperative assessment; a.) Mild: stable vital signs with mild residual symptoms, b.) Severe: respiration rate &#x02265;30/min, resting arterial oxygen saturation (SaO<sub>2</sub> &#x02264;93%), Critical: shock with organ failure, respiratory failure requiring mechanical ventilation, or refractory hypoxemia.[<xref rid="R43" ref-type="bibr">43</xref>] Based on the clinical evaluation, a multidisciplinary approach, along with an assessment of appropriate postoperative respiratory care is to be adopted.</p></list-item><list-item><p>History of duration and severity of COVID-19, along with associated comorbidities should be noted along with their residual effects.[<xref rid="R44" ref-type="bibr">44</xref>]</p></list-item><list-item><p>Based on the indication of cesarean section, the severity of symptoms, presence of comorbidities (preeclampsia, cardiac, respiratory disease), obstetric history, and fetal condition, the timing of delivery can be individualized. In the absence of fetal distress and mild symptoms, pregnancy can be continued.[<xref rid="R45" ref-type="bibr">45</xref>]</p></list-item><list-item><p><bold>Post-COVID syndrome:</bold> The Center for Disease Control (CDC) has coined the term post-acute COVID-19 syndrome for the patients who recovered from SARS-CoV-2 infection characterized by the persistence of clinical symptoms beyond 4 weeks from the onset of acute symptoms. It consists of a myriad of symptoms including tiredness, dyspnea, fatigue, brain fogginess, autonomic dysfunction, headache, persistent loss of smell or taste, cough, depression, low-grade fevers, palpitations, dizziness, muscle pain, and joint pains. These further mandate the evaluation of the multiorgan effect of post-COVID infection on various organ systems.[<xref rid="R46" ref-type="bibr">46</xref>]</p></list-item><list-item><p><bold>Cardiovascular system:</bold> Cardiomyopathies, myocardial infarction, arrhythmias, and myocarditis are commonly associated complications with the recovered COVID-19 patients, warranting cardiac evaluation in SARS-CoV-2-recovered parturients.[<xref rid="R47" ref-type="bibr">47</xref>] Furthermore, cardiac and normal pregnancy symptoms including dyspnea on exertion, palpitations, tachycardia, and syncope are two sides of the same coin, thus, necessitating prompt differentiation between the two entities.</p></list-item><list-item><p><bold>Respiratory system:</bold> The evaluation of pulmonary sequelae after SARS-CoV-2 infection is cardinal. Effort tolerance after post-COVID-19 infection is subjective, albeit a 6-min walk test and breath-holding time are fairly objective. This aforementioned, non-invasive test can be conducted at the time of a pre-anesthesia checkup (PAC), if feasible.[<xref rid="R48" ref-type="bibr">48</xref>]</p></list-item><list-item><p><bold>Neurological system:</bold> Post-viral symptoms are compiled under the parasol term of &#x0201c;post-COVID-19 syndrome.&#x0201d;[<xref rid="R49" ref-type="bibr">49</xref>] Symptoms including headache, neuromuscular weakness, depression, or any cerebrovascular accidents need to be properly evaluated at the time of PAC and properly documented, as they may have important implications during the intraoperative and postoperative period.[<xref rid="R49" ref-type="bibr">49</xref>]</p></list-item><list-item><p><bold>Anticoagulants:</bold> Obstetric patients who recovered from SARS-CoV-2 infection can be on antiplatelet or antithrombotic agents. A detailed history of the drug and clear instructions regarding the timing of stoppage and continuation should be given during the pre-anesthetic checkup. Low dose aspirin (75&#x02013;150 mg/day) can be continued safely, clopidogrel should be stopped 5 days before surgery and resumed 24 h postoperatively in high-risk cardiac event patients.[<xref rid="R23" ref-type="bibr">23</xref>] Dual-antiplatelet therapy can be discontinued 7&#x02013;10 days before surgery and resumed 23 h postoperatively in the low-risk of cardiac events parturients. Prophylactic and therapeutic doses of low molecular weight heparin (LMWH) should be stopped at 12 and 24 h, respectively, after the last dose.</p></list-item><list-item><p><bold>Comorbidity:</bold> The history of comorbidity and preoperative optimization as far as possible is cardinal in these subsets as there can be worsening of comorbidities in the recovered COVID-19 patients</p></list-item><list-item><p><bold>Psychological counseling:</bold> Post-COVID-19 recovered patients are in a state of post-trauma stress with anxiety and depression. Nonetheless, they generally have increased anxiety and are worried about the neonatal outcome. Hence, they may require immediate psychological counseling from an expert.</p></list-item><list-item><p><bold>Vaccination history:</bold> The history of COVID-19 vaccination should be elicited.</p></list-item><list-item><p><bold>Venous access:</bold> The propensity for venous thrombosis in the post-COVID-19 recovered patient may lead to difficulties in venous access. Therefore, veins need to be checked preoperatively and central venous cannulation can be considered, depending upon the overall assessment of the patient.</p></list-item><list-item><p><bold>Requirement of oxygenation:</bold> The shift of the diaphragm due to the growing uterus, reduction in FRC, and increased oxygen consumption result in the increased requirement of oxygen in pregnancy. Indeed, post-COVID-19 pulmonary fibrosis or other respiratory sequelae can further increase the oxygen requirement, and hence, functional assessment of oxygen requirement intra- and postoperatively is imperative. Also, the need for postoperative ventilation needs to be duly addressed preoperatively.</p></list-item><list-item><p><bold>Drug allergy:</bold> History of old drug allergy or newly developed drug allergy due to anti-COVID-19 drugs or COVID-19 vaccine should be asked, as ignorance may lead to anaphylaxis or any other catastrophic event intraoperatively.</p></list-item></list>
</p></sec><sec><title>Investigations</title><p>The goal of the investigations should be based on the evaluation of post-COVID-19 illness sequelae, functional evaluation of various organs, and associated comorbidities. Special investigations in a post-COVID-19 obstetric patient may vary from patient to patient and should be individualized depending upon the clinical scenario, presence of comorbidities, and institutional protocol. Any of the abnormal values in this battery of special investigations suggest that the disease sequelae are persisting and are not completely resolved, thereby, indicating a higher risk of intra/perioperative complications [<xref rid="joacp_550_21-t004" ref-type="table">Table 4</xref>].</p><table-wrap position="float" id="joacp_550_21-t004"><label>Table 4</label><caption><p>Battery of routine and special investigations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Routine Investigations</th><th align="left" rowspan="1" colspan="1">Special Investigations for post-COVID recovery status</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Coagulation profile: BT, CT, PT, INR, APTT, platelet <break/>Serum Electrolytes: Sodium, Potassium, and calcium <break/>RFTs: BUN, Serum Creatinine <break/>LFT <break/>TLC <break/>COVID Antibody IgM/IgG Tests <break/>Blood culture, if the count is very high</td><td align="left" rowspan="1" colspan="1">D-dimer <break/>LDH/Ferritin/prealbumin <break/>Fibrinogen <break/>Serum lactate <break/>2 D Echo who had moderate/severe hypoxia or significant cardiac symptoms during COVID19 <break/>ECG <break/>PFT; If feasible <break/>ABG <break/>Troponin <break/>HRCT (High-resolution computed tomography) needs to be done in patients who had mild hypoxia (53.9%) <break/>MRI can be done in hospitalized and recovered patients to find out any abnormalities <break/>CT/MRI brain in case of neurological involvement or patient on anticoagulants to rule out any intracranial hemorrhage <break/>POCUS</td></tr></tbody></table><table-wrap-foot><fn><p>BT: Bleeding time; CT:Clotting time; PT: Prothrombin time; INR:International normalized ratio; APTT: Activated partial thromboplastin time; LDH: Lactate dehydrogenase; LFT: Liver function tests; TLC: Total leucocyte count; ABG: Arterial blood gas; PFT: Pulmonary function tests; ECG: Electrocardiogram; MRI: Magnetic resonance imaging; CT: Computed totomography; POCUS: Point of care ultrasound; Ig: Immunoglobulin</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Perioperative concerns</title><p>
<list list-type="order"><list-item><p>Monitoring: Standard American Society of Anesthesiologists (ASA) monitoring including a pulse oximeter, electrocardiography (ECG), non-invasive blood pressure, end-tidal carbon dioxide (ETCO<sub>2</sub>), and temperature monitoring are to be done in all pregnant patients requiring surgical intervention.[<xref rid="R50" ref-type="bibr">50</xref>]</p></list-item><list-item><p>The goal of oxygen therapy is to maintain oxygen saturation above 95&#x02013;96% in a post-COVID-19 recovered obstetric patient.[<xref rid="R50" ref-type="bibr">50</xref>] It is noteworthy that recovered patients may have decreased saturation and anesthesia drugs may further cause desaturation, hence, warranting supplementary oxygenation. Pregnancy is a state of increased oxygen consumption and decreased oxygen levels are not only detrimental to the mother but may cause fetal distress and enhance mortality and morbidity. Tools including modified early obstetric warning systems (MEOWS) can be helpful.[<xref rid="R51" ref-type="bibr">51</xref>] Also, an increased need for oxygen is a sign of deterioration.[<xref rid="R52" ref-type="bibr">52</xref>]</p></list-item><list-item><p>Anti-aspiration prophylaxis, H<sub>2</sub> blocker, and/or metoclopramide for aspiration prophylaxis can be used to decrease the risk of aspiration due to reduced lower esophageal sphincter tone, particularly after 16 weeks of pregnancy.[<xref rid="R53" ref-type="bibr">53</xref><xref rid="R54" ref-type="bibr">54</xref>]</p></list-item><list-item><p>There is compression of inferior vena cava (IVC) due to the gravid uterus causing supine hypotension syndrome. Keeping a wedge under the right lower back or 10&#x02013;15&#x000b0; left lateral table tilt can be useful for the same.[<xref rid="R18" ref-type="bibr">18</xref>]</p></list-item><list-item><p>The choice of anesthesia depends upon the emergency/urgency of the cesarean section and should be tailored based on the fetal, obstetric, and anesthesia risks involved.[<xref rid="R23" ref-type="bibr">23</xref>] Neuraxial anesthesia is recommended as first-line in post-COVID-19 recovered patients both for elective and emergency cesarean section.[<xref rid="R38" ref-type="bibr">38</xref>]</p></list-item><list-item><p>If the patient is on anticoagulants, she should not receive regional anesthesia.[<xref rid="R23" ref-type="bibr">23</xref>]An early epidural to prevent the chance of an emergency cesarean section under general anesthesia, recent platelet count, keeping in mind the possibility of thrombocytopenia and other coagulation abnormalities due to antiplatelet or antithrombotic drugs are recommended for neuraxial blockade[<xref rid="R55" ref-type="bibr">55</xref>] in the post-COVID-19 state. The American Society of Regional Anesthesia (ASRA) institutional guidelines should be followed before administration of regional anesthesia, and there exists no strong evidence on any particular neuraxial technique more advantageous than others; hence, the decision depends on the discretion of the anesthesiologist.</p></list-item><list-item><p>Labor analgesia: Early labor analgesia is recommended to avoid general anesthesia in case of emergency and can also be used for postoperative pain relief. Patient-controlled epidural analgesia (PCEA) can be used for giving labor analgesia.</p></list-item><list-item><p>Goal-directed fluid therapy can be instituted. Overzealous fluid overloading should be avoided. The COVID-19 recovered parturient may become hypotensive (18%) during regional anesthesia or induction of anesthesia. Prophylactic vasopressors, namely phenylephrine/ephedrine are preferred over fluid overloading. In a multicenter, retrospective, propensity score-matched cohort study, the incidence of neuraxial anesthesia-related hypotension was 57.4% in the COVID-19 parturients and 41.9% in control parturients.[<xref rid="R56" ref-type="bibr">56</xref>] Another retrospective review of the patients with a history of COVID-19 infection revealed abnormal cardiovagal function in 275 cases, orthostatic symptoms including postural orthostatic syndrome in 22% of the cases, and orthostatic intolerance in 11% of the cases between 0 and 122 days post-infection. Post-COVID-19 autonomic and small fiber neuropathy can occur.[<xref rid="R57" ref-type="bibr">57</xref>] Nevertheless, low cortisol levels and adrenal insufficiency have also been reported as post-COVID -19 sequelae.[<xref rid="R58" ref-type="bibr">58</xref>]</p></list-item><list-item><p>Cross-matching of blood and an adequate arrangement of blood and blood products should be ensured, depending on the requirement of the case.</p></list-item><list-item><p>General anesthesia (GA) can be administered depending upon maternal emergency (severe pre-eclampsia/eclampsia/HELLP (hemolysis, elevated liver enzymes, low platelet count)), contraindication to regional anesthesia (severe thrombocytopenia, failed RA, coagulopathy), or fetal emergency (cord prolapse, severe fetal distress).</p><p>GA should be preferred in patients with decreased cardio-pulmonary reserve. Rapid sequence induction is employed and a higher fraction of inspired oxygen (FiO<sub>2</sub>) has to be maintained till fetal delivery to ensure adequate fetal oxygenation.[<xref rid="R23" ref-type="bibr">23</xref>]</p></list-item><list-item><p>Patients receiving magnesium sulphate (MgSO<sub>4</sub>) should be carefully observed for any respiratory muscle weakness. This mandates its judicious use in patients with respiratory distress.</p></list-item><list-item><p>Preoxygenation is recommended in COVID-19 recovered parturients because of decreased FRC and an increased vulnerability to desaturation. Video laryngoscope-aided intubation should be preferred due to the high chance of first-pass success rate. A difficult airway cart has to be kept ready because of altered airway anatomy in a pregnant patient. According to the difficult airway algorithm, second-generation supraglottic airway devices can be used as a part of the rescue plan in cannot intubate/ventilate situation.</p></list-item><list-item><p>The post-COVID-19 recovered obstetric patients are prone to AKI intraoperatively, and hence, reno-toxic drugs should be avoided and urine output should be maintained above 0.5&#x02013;1 mL/h.</p></list-item><list-item><p>In a diabetic parturient, perioperative perturbations in blood sugar levels should be avoided. Tight glycemic control is now being perceived as a perioperative goal in patients undergoing surgery.[<xref rid="R59" ref-type="bibr">59</xref><xref rid="R60" ref-type="bibr">60</xref>] Although there exist no robust guidelines for the target glycemic control intraoperatively, albeit blood glucose can be titrated to 80&#x02013;120 mg/dL, and an institutional insulin infusion protocol can be followed.[<xref rid="R61" ref-type="bibr">61</xref>]</p></list-item><list-item><p>Although, there is a lack of evidence supporting the vertical transmission of the SARS-CoV-2 infection in the neonate from the mother, standard neonatal resuscitation guidelines are to be followed and an emergency cart including resuscitation drugs, suction, oxygen, and intubation trolley should be kept ready. Neonatologists are to be kept informed and available to assess the neonate&#x02019;s well-being.</p></list-item></list>
</p></sec><sec><title>Postoperative concerns</title><p>
<list list-type="order"><list-item><p>Standard postoperative monitoring with a focus on continuous oxygen monitoring via pulse oximetry is mandatory.</p></list-item><list-item><p>Multimodal analgesia can be used for enhanced recovery after cesarean section (postoperative pain relief),[<xref rid="R62" ref-type="bibr">62</xref>] and there exists no evidence against the use of non-steroidal anti-inflammatory drugs (NSAIDs) in the post-COVID-19 recovered patient. Postoperative pain may worsen hypoxia, and tachycardia and produce an overall increase in the work of breathing.</p></list-item><list-item><p>The following criteria denote intensive care unit (ICU) admission: Respiratory rate &#x0003e;30/min, desaturation (&#x0003c;92-93%) at rest, FiO<sub>2</sub> &#x0003c;300 mmHg. The Quick Sequential Organ Failure Assessment Score (qSOFA) can also be used as an adjunct for making the final decision.</p></list-item><list-item><p>Post-COVID-19 recovered patients are prone to post-dural puncture headache (PDPH) and should be managed promptly with adequate rest, judicious fluids, NSAIDs, and caffeine. Epidural saline is preferred over an autologous blood patch.</p></list-item><list-item><p>Antiplatelet, anticoagulant, LMWH, and other drugs can be continued as per the recommended guidelines.</p></list-item><list-item><p>Early mobilization should be encouraged, as both pregnancy and post-COVID recovered states are considered hypercoagulable states, thereby, necessitating deep vein thrombosis (DVT) prophylaxis.</p></list-item><list-item><p>Psychological well-being is very important in the COVID-19 recovered patients, and the literature has reported severe post-partum depression in SARS-CoV-2 -recovered patients. Prompt recognition and identification of depression and anxiety symptoms in a parturient along with proper psychological counseling and treatment are pivotal.</p></list-item><list-item><p>Breastfeeding can be encouraged.</p></list-item></list>
</p></sec></sec><sec sec-type="conclusion"><title>Conclusion</title><p>Successful management of the post-COVID-19 recovered obstetric patient requires multidisciplinary teamwork and anesthesiologists form an integral part of the team. Neuraxial anesthesia and analgesia seem to be effective and safe in the recovered COVID-19 obstetric patients. It is of utmost importance to establish standard care definitions in this important subset. The goal of anesthesia management should focus on the recognition of the sequelae of the COVID-19 infection in the parturient with the aim of preoperative optimization, goal-directed fluid therapy, protective intraoperative ventilatory strategies, adequate analgesia, and early ambulation.</p><sec><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>R</given-names></name>
<name><surname>Saxena</surname><given-names>A</given-names></name>
<name><surname>Magoon</surname><given-names>R</given-names></name>
<name><surname>Jain</surname><given-names>MK</given-names></name>
</person-group><article-title>A cross-sectional analysis of prevalence and factors related to depression, anxiety, and stress in health care workers amidst the COVID-19 pandemic</article-title><source>Indian J Anaesth</source><year>2020</year><volume>64</volume><issue>Suppl 4</issue><fpage>S242</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">33311726</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>P</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Song</surname><given-names>Y</given-names></name>
</person-group><article-title>Characteristics and pregnancy outcomes of patients with severe pneumonia complicating pregnancy: A retrospective study of 12 cases and a literature review</article-title><source>BMC Pregnancy Childbirth</source><year>2018</year><volume>18</volume><fpage>434</fpage><pub-id pub-id-type="pmid">30390683</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="webpage" publication-format="web"><source>Centers for Disease Control and Prevention. Pregnant and recently pregnant people at increased risk for severe illness from COVID-19</source><comment>Available from: <uri xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnant-people.html">https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnant-people.html</uri></comment><date-in-citation>Last accessed on 2022 Feb 06</date-in-citation></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Mullins</surname><given-names>E</given-names></name>
<name><surname>Evans</surname><given-names>D</given-names></name>
<name><surname>Viner</surname><given-names>RM</given-names></name>
<name><surname>O&#x02019;Brien</surname><given-names>P</given-names></name>
<name><surname>Morris</surname><given-names>E</given-names></name>
</person-group><article-title>Coronavirus in pregnancy and delivery: Rapid review</article-title><source>Ultrasound Obstet Gynecol</source><year>2020</year><volume>55</volume><fpage>586</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">32180292</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Schwartz</surname><given-names>DA</given-names></name>
</person-group><article-title>An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: Maternal coronavirus infections and pregnancy outcomes</article-title><source>Arch Pathol Lab Med</source><year>2020</year><volume>144</volume><fpage>799</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">32180426</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="webpage" publication-format="web"><source>WHO. Coronavirus disease (COVID-19): Pregnancy and childbirth. WHO</source><year>2021</year><comment>Available from: <uri xlink:href="https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-pregnancy-and-childbirth">https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-pregnancy-and-childbirth</uri></comment><date-in-citation>Last accessed on 2021 Apr 16</date-in-citation></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="book" publication-format="print"><person-group person-group-type="author">
<name><surname>Cascella</surname><given-names>M</given-names></name>
<name><surname>Rajnik</surname><given-names>M</given-names></name>
<name><surname>Aleem</surname><given-names>A</given-names></name>
<name><surname>Dulebohn</surname><given-names>SC</given-names></name>
<name><surname>Di Napoli</surname><given-names>R</given-names></name>
</person-group><article-title>Features, Evaluation, and Treatment of Coronavirus (COVID-19). In: StatPearls</article-title><publisher-loc>Treasure Island (FL)</publisher-loc><publisher-name>StatPearls Publishing</publisher-name><year>2021</year></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Jamieson</surname><given-names>DJ</given-names></name>
<name><surname>Theiler</surname><given-names>RN</given-names></name>
<name><surname>Rasmussen</surname><given-names>SA</given-names></name>
</person-group><article-title>Emerging infections and pregnancy</article-title><source>Emerg Infect Dis</source><year>2006</year><volume>12</volume><fpage>1638</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">17283611</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Silasi</surname><given-names>M</given-names></name>
<name><surname>Cardenas</surname><given-names>I</given-names></name>
<name><surname>Kwon</surname><given-names>JY</given-names></name>
<name><surname>Racicot</surname><given-names>K</given-names></name>
<name><surname>Aldo</surname><given-names>P</given-names></name>
<name><surname>Mor</surname><given-names>G</given-names></name>
</person-group><article-title>Viral infections during pregnancy</article-title><source>Am J Reprod Immunol</source><year>2015</year><volume>73</volume><fpage>199</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">25582523</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Weiss</surname><given-names>SR</given-names></name>
<name><surname>Navas-Martin</surname><given-names>S</given-names></name>
</person-group><article-title>Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus</article-title><source>Microbiol Molec Biol Rev</source><year>2005</year><volume>69</volume><fpage>635</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16339739</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Coutard</surname><given-names>B</given-names></name>
<name><surname>Valle</surname><given-names>C</given-names></name>
<name><surname>de Lamballerie</surname><given-names>X</given-names></name>
<name><surname>Canard</surname><given-names>B</given-names></name>
<name><surname>Seidah</surname><given-names>NG</given-names></name>
<name><surname>Decroly</surname><given-names>E</given-names></name>
</person-group><article-title>The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade</article-title><source>Antiviral Res</source><year>2020</year><volume>176</volume><fpage>104742</fpage><pub-id pub-id-type="pmid">32057769</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Glowacka</surname><given-names>I</given-names></name>
<name><surname>Bertram</surname><given-names>S</given-names></name>
<name><surname>Herzog</surname><given-names>P</given-names></name>
<name><surname>Pfefferle</surname><given-names>S</given-names></name>
<name><surname>Steffen</surname><given-names>I</given-names></name>
<name><surname>Muench</surname><given-names>MO</given-names></name>
<etal/>
</person-group><article-title>Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63</article-title><source>J Virol</source><year>2010</year><volume>84</volume><fpage>1198</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">19864379</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>West</surname><given-names>CA</given-names></name>
<name><surname>Sasser</surname><given-names>JM</given-names></name>
<name><surname>Baylis</surname><given-names>C</given-names></name>
</person-group><article-title>The enigma of continual plasma volume expansion in pregnancy: Critical role of the renin-angiotensin-aldosterone system</article-title><source>Am J Physiol Renal Physiol</source><year>2016</year><volume>311</volume><fpage>F1125</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">27707703</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Bhatia</surname><given-names>P</given-names></name>
<name><surname>Chhabra</surname><given-names>S</given-names></name>
</person-group><article-title>Physiological and anatomical changes of pregnancy: Implications for anaesthesia</article-title><source>Indian J Anaesth</source><year>2018</year><volume>62</volume><fpage>651</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">30237589</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>H</given-names></name>
<name><surname>Han</surname><given-names>X</given-names></name>
<name><surname>Jiang</surname><given-names>N</given-names></name>
<name><surname>Cao</surname><given-names>Y</given-names></name>
<name><surname>Alwalid</surname><given-names>O</given-names></name>
<name><surname>Gu</surname><given-names>J</given-names></name>
<etal/>
</person-group><article-title>Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study</article-title><source>Lancet Infect Dis</source><year>2020</year><volume>20</volume><fpage>425</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">32105637</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Mo</surname><given-names>X</given-names></name>
<name><surname>Jian</surname><given-names>W</given-names></name>
<name><surname>Su</surname><given-names>Z</given-names></name>
<name><surname>Chen</surname><given-names>M</given-names></name>
<name><surname>Peng</surname><given-names>H</given-names></name>
<name><surname>Peng</surname><given-names>P</given-names></name>
<etal/>
</person-group><article-title>Abnormal pulmonary function in COVID-19 patients at time of hospital discharge</article-title><source>Eur Respir J</source><year>2020</year><volume>55</volume><fpage>2001217</fpage><pub-id pub-id-type="pmid">32381497</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>You</surname><given-names>J</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Ni-Jia-Ti</surname><given-names>MY</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Hu</surname><given-names>F</given-names></name>
<name><surname>Chen</surname><given-names>L</given-names></name>
<etal/>
</person-group><article-title>Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge</article-title><source>J Infect</source><year>2020</year><volume>81</volume><fpage>e150</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">32512021</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Bajwa</surname><given-names>SJ</given-names></name>
<name><surname>Bajwa</surname><given-names>SK</given-names></name>
</person-group><article-title>Anaesthetic challenges and management during pregnancy: Strategies revisited</article-title><source>Anesth Essays Res</source><year>2013</year><volume>7</volume><fpage>160</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">25885826</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Fumagalli</surname><given-names>A</given-names></name>
<name><surname>Misuraca</surname><given-names>C</given-names></name>
<name><surname>Bianchi</surname><given-names>A</given-names></name>
<name><surname>Borsa</surname><given-names>N</given-names></name>
<name><surname>Limonta</surname><given-names>S</given-names></name>
<name><surname>Maggiolini</surname><given-names>S</given-names></name>
<etal/>
</person-group><article-title>Pulmonary function in patients surviving to COVID-19 pneumonia</article-title><source>Infection</source><year>2020</year><volume>49</volume><fpage>153</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">32725597</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>YM</given-names></name>
<name><surname>Shang</surname><given-names>YM</given-names></name>
<name><surname>Song</surname><given-names>WB</given-names></name>
<name><surname>Li</surname><given-names>QQ</given-names></name>
<name><surname>Xie</surname><given-names>H</given-names></name>
<name><surname>Xu</surname><given-names>QF</given-names></name>
<etal/>
</person-group><article-title>Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery</article-title><source>EClinicalMedicine</source><year>2020</year><volume>25</volume><fpage>100463</fpage><pub-id pub-id-type="pmid">32838236</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Hui</surname><given-names>DS</given-names></name>
<name><surname>Joynt</surname><given-names>GM</given-names></name>
<name><surname>Wong</surname><given-names>KT</given-names></name>
<name><surname>Gomersall</surname><given-names>CD</given-names></name>
<name><surname>Li</surname><given-names>TS</given-names></name>
<name><surname>Antonio</surname><given-names>G</given-names></name>
<etal/>
</person-group><article-title>Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors</article-title><source>Thorax</source><year>2005</year><volume>60</volume><fpage>401</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15860716</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Guler</surname><given-names>SA</given-names></name>
<name><surname>Ebner</surname><given-names>L</given-names></name>
<name><surname>Aubry-Beigelman</surname><given-names>C</given-names></name>
<name><surname>Bridevaux</surname><given-names>PO</given-names></name>
<name><surname>Brutsche</surname><given-names>M</given-names></name>
<name><surname>Clarenbach</surname><given-names>C</given-names></name>
<etal/>
</person-group><article-title>Pulmonary function and radiological features 4 months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study</article-title><source>Eur Respir J</source><year>2021</year><volume>57</volume><fpage>2003690</fpage><pub-id pub-id-type="pmid">33419891</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Malhotra</surname><given-names>N</given-names></name>
<name><surname>Bajwa</surname><given-names>SJ</given-names></name>
<name><surname>Joshi</surname><given-names>M</given-names></name>
<name><surname>Mehdiratta</surname><given-names>L</given-names></name>
<name><surname>Hemantkumar</surname><given-names>I</given-names></name>
<name><surname>Rani</surname><given-names>RA</given-names></name>
<etal/>
</person-group><article-title>Perioperative management of post-COVID-19 surgical patients: Indian Society of Anaesthesiologists (ISA National) advisory and position statement</article-title><source>Indian J Anaesth</source><year>2021</year><volume>65</volume><fpage>499</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">34321679</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>McClelland</surname><given-names>SH</given-names></name>
<name><surname>Bogod</surname><given-names>DG</given-names></name>
<name><surname>Hardman</surname><given-names>JG</given-names></name>
</person-group><article-title>Apnea in pregnancy: An investigation using physiological modelling</article-title><source>Anaesthesia</source><year>2008</year><volume>63</volume><fpage>264</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18289232</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>K</given-names></name>
<name><surname>Zhang</surname><given-names>W</given-names></name>
<name><surname>Yang</surname><given-names>Y</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Chen</surname><given-names>Y</given-names></name>
</person-group><article-title>Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study</article-title><source>Complement Ther Clin Pract</source><year>2020</year><volume>39</volume><fpage>101166</fpage><pub-id pub-id-type="pmid">32379637</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Callaghan</surname><given-names>BC</given-names></name>
<name><surname>Reynolds</surname><given-names>EL</given-names></name>
<name><surname>Banerjee</surname><given-names>M</given-names></name>
<name><surname>Chant</surname><given-names>E</given-names></name>
<name><surname>Villegas-Umana</surname><given-names>E</given-names></name>
<name><surname>Gardner</surname><given-names>TW</given-names></name>
</person-group><article-title>The prevalence and determinants of cognitive deficits and traditional diabetic complications in the severely obese</article-title><source>Diabetes Care</source><year>2020</year><volume>43</volume><fpage>683</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">31932459</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Babapoor-Farrokhran</surname><given-names>S</given-names></name>
<name><surname>Gill</surname><given-names>D</given-names></name>
<name><surname>Walker</surname><given-names>J</given-names></name>
<name><surname>Rasekhi</surname><given-names>RT</given-names></name>
<name><surname>Bozorgnia</surname><given-names>B</given-names></name>
<name><surname>Amanullah</surname><given-names>A</given-names></name>
</person-group><article-title>Myocardial injury and COVID-19: Possible mechanisms</article-title><source>Life Sci</source><year>2020</year><volume>253</volume><fpage>117723</fpage><pub-id pub-id-type="pmid">32360126</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Kinsella</surname><given-names>SM</given-names></name>
<name><surname>Lohmann</surname><given-names>G</given-names></name>
</person-group><article-title>Supine hypotensive syndrome</article-title><source>Obstet Gynecol</source><year>1994</year><volume>83</volume><fpage>774</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">8164943</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Lanni</surname><given-names>SM</given-names></name>
<name><surname>Tillinghast</surname><given-names>J</given-names></name>
<name><surname>Silver</surname><given-names>HM</given-names></name>
</person-group><article-title>Hemodynamic changes and baroreflex gain in the supine hypotensive syndrome</article-title><source>Am J Obstet Gynecol</source><year>2002</year><volume>187</volume><fpage>1636</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">12501076</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Guan</surname><given-names>WJ</given-names></name>
<name><surname>Ni</surname><given-names>ZY</given-names></name>
<name><surname>Hu</surname><given-names>Y</given-names></name>
<name><surname>Liang</surname><given-names>WH</given-names></name>
<name><surname>Ou</surname><given-names>CQ</given-names></name>
<name><surname>He</surname><given-names>JX</given-names></name>
<etal/>
</person-group><article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title><source>N Engl J Med</source><year>2020</year><volume>382</volume><fpage>1708</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">32109013</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="book" publication-format="print"><person-group person-group-type="author">
<name><surname>Nelson-Piercy</surname><given-names>C</given-names></name>
</person-group><article-title>Respiratory disease</article-title><source>Handbook of Obstetric Medicine</source><year>2015</year><publisher-loc>Boca Raton, FL</publisher-loc><publisher-name>CRC Press</publisher-name><fpage>63</fpage><lpage>84</lpage></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Berger</surname><given-names>A</given-names></name>
</person-group><article-title>Th1 and Th2 responses: What are they?</article-title><source>BMJ</source><year>2000</year><volume>321</volume><fpage>424</fpage><pub-id pub-id-type="pmid">10938051</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>C</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Ren</surname><given-names>L</given-names></name>
<name><surname>Zhao</surname><given-names>J</given-names></name>
<name><surname>Hu</surname><given-names>Y</given-names></name>
<etal/>
</person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">31986264</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Ruan</surname><given-names>Q</given-names></name>
<name><surname>Yang</surname><given-names>K</given-names></name>
<name><surname>Wang</surname><given-names>W</given-names></name>
<name><surname>Jiang</surname><given-names>L</given-names></name>
<name><surname>Song</surname><given-names>J</given-names></name>
</person-group><article-title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title><source>Intensive Care Med</source><year>2020</year><volume>46</volume><fpage>846</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">32125452</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Rasmussen</surname><given-names>SA</given-names></name>
<name><surname>Jamieson</surname><given-names>DJ</given-names></name>
<name><surname>Macfarlane</surname><given-names>K</given-names></name>
<name><surname>Cragan</surname><given-names>JD</given-names></name>
<name><surname>Williams</surname><given-names>J</given-names></name>
<name><surname>Henderson</surname><given-names>Z</given-names></name>
</person-group><article-title>Pandemic Influenza and Pregnancy Working Group. Pandemic influenza and pregnant women: Summary of a meeting of experts</article-title><source>Am J Public Health</source><year>2009</year><volume>99</volume><issue>Suppl 2</issue><fpage>S248</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">19461110</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Mor</surname><given-names>G</given-names></name>
<name><surname>Aldo</surname><given-names>P</given-names></name>
<name><surname>Alvero</surname><given-names>AB</given-names></name>
</person-group><article-title>The unique immunological and microbial aspects of pregnancy</article-title><source>Nat Rev Immunol</source><year>2017</year><volume>17</volume><fpage>469</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">28627518</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Breslin</surname><given-names>N</given-names></name>
<name><surname>Baptiste</surname><given-names>C</given-names></name>
<name><surname>Miller</surname><given-names>R</given-names></name>
<name><surname>Fuchs</surname><given-names>K</given-names></name>
<name><surname>Goffman</surname><given-names>D</given-names></name>
<name><surname>Gyamfi-Bannerman</surname><given-names>C</given-names></name>
<etal/>
</person-group><article-title>COVID-19 in pregnancy: Early lessons</article-title><source>Am J Obstet Gynecol MFM</source><year>2020</year><volume>2</volume><fpage>100111</fpage><pub-id pub-id-type="pmid">32518902</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Breslin</surname><given-names>N</given-names></name>
<name><surname>Baptiste</surname><given-names>C</given-names></name>
<name><surname>Gyamfi-Bannerman</surname><given-names>C</given-names></name>
<name><surname>Miller</surname><given-names>R</given-names></name>
<name><surname>Martinez</surname><given-names>R</given-names></name>
<name><surname>Bernstein</surname><given-names>K</given-names></name>
<etal/>
</person-group><article-title>COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals</article-title><source>Am J Obstet Gynecol MFM. Am J Obstet Gynecol MFM</source><year>2020</year><volume>2</volume><fpage>100118</fpage><pub-id pub-id-type="pmid">32292903</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Narang</surname><given-names>K</given-names></name>
<name><surname>Enninga</surname><given-names>EAL</given-names></name>
<name><surname>Gunaratne</surname><given-names>MDSK</given-names></name>
<name><surname>Ibirogba</surname><given-names>ER</given-names></name>
<name><surname>Trad</surname><given-names>ATA</given-names></name>
<name><surname>Elrefaei</surname><given-names>A</given-names></name>
<etal/>
</person-group><article-title>SARS-CoV-2 infection and COVID-19 during pregnancy: A multidisciplinary review</article-title><source>Mayo Clin Proc</source><year>2020</year><volume>95</volume><fpage>1750</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">32753148</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Bajwa</surname><given-names>SJ</given-names></name>
<name><surname>Sharma</surname><given-names>R</given-names></name>
<name><surname>Kurdi</surname><given-names>MS</given-names></name>
</person-group><article-title>The stress of COVID-19: Playing havoc with the hormones-A review</article-title><source>J Endocrinol Res</source><year>2021</year><volume>2</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Guan</surname><given-names>WJ</given-names></name>
<name><surname>Liang</surname><given-names>WH</given-names></name>
<name><surname>Zhao</surname><given-names>Y</given-names></name>
<name><surname>Liang</surname><given-names>HR</given-names></name>
<name><surname>Chen</surname><given-names>ZS</given-names></name>
<name><surname>Li</surname><given-names>YM</given-names></name>
<etal/>
</person-group><article-title>Comorbidity and its impact on 1,590 patients with COVID-19 in China: A nationwide analysis</article-title><source>medRxiv</source><year>2020</year><comment>doi: 10.1101/2020.02.25.20027664</comment></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>S</given-names></name>
<name><surname>Zhang</surname><given-names>X</given-names></name>
<name><surname>Xu</surname><given-names>H</given-names></name>
</person-group><article-title>Don&#x02019;t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19)</article-title><source>Clin Gastroenterol Hepatol</source><year>2020</year><volume>18</volume><fpage>1636</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">32205220</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Torrielli</surname><given-names>R</given-names></name>
<name><surname>Mene</surname><given-names>JM</given-names></name>
<name><surname>Noblia</surname><given-names>M</given-names></name>
</person-group><article-title>[Mendelson&#x02019;s syndrome in obstetrics. History or fact?]</article-title><source>J Gynecol Obstet Biol Reprod</source><year>1989</year><volume>18</volume><fpage>93</fpage><lpage>8</lpage></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Lei</surname><given-names>S</given-names></name>
<name><surname>Jiang</surname><given-names>F</given-names></name>
<name><surname>Su</surname><given-names>W</given-names></name>
<name><surname>Chen</surname><given-names>C</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Mei</surname><given-names>W</given-names></name>
<etal/>
</person-group><article-title>Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID19 infection</article-title><source>EClinicalMedicine</source><year>2020</year><volume>21</volume><fpage>100331</fpage><pub-id pub-id-type="pmid">32292899</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>H</given-names></name>
<name><surname>Acharya</surname><given-names>G</given-names></name>
</person-group><article-title>Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?</article-title><source>Acta Obstet Gynecol Scand</source><year>2020</year><volume>99</volume><fpage>439</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">32141062</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Hoyler</surname><given-names>MM</given-names></name>
<name><surname>White</surname><given-names>RS</given-names></name>
<name><surname>Tam</surname><given-names>CW</given-names></name>
<name><surname>Thalappillil</surname><given-names>R</given-names></name>
</person-group><article-title>Anesthesia and the &#x0201c;post-COVID syndrome&#x0201d;: Perioperative considerations for patients with prior SARS-CoV-2 infection</article-title><source>J Clin Anesth</source><year>2021</year><volume>72</volume><fpage>110</fpage><lpage>283</lpage></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Petrovic</surname><given-names>V</given-names></name>
<name><surname>Radenkovic</surname><given-names>D</given-names></name>
<name><surname>Radenkovic</surname><given-names>G</given-names></name>
<name><surname>Djordjevic</surname><given-names>V</given-names></name>
<name><surname>Banach</surname><given-names>M</given-names></name>
</person-group><article-title>Pathophysiology of cardiovascular complications in COVID-19</article-title><source>Front Physiol</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">32038307</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Wajekar</surname><given-names>AS</given-names></name>
<name><surname>Solanki</surname><given-names>SL</given-names></name>
<name><surname>Divatia</surname><given-names>JV</given-names></name>
</person-group><article-title>Pre-anesthesia re-evaluation in post COVID-19 patients posted for elective surgeries: An online, cross-sectional survey [published online ahead of print, 2021 May 17]</article-title><source>Indian J Surg Oncol</source><year>2021</year><volume>12</volume><issue>Suppl 2</issue><fpage>234</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">34025062</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Bui</surname><given-names>N</given-names></name>
<name><surname>Coetzer</surname><given-names>M</given-names></name>
<name><surname>Schenning</surname><given-names>KJ</given-names></name>
<name><surname>O&#x02019;Glasser</surname><given-names>AY</given-names></name>
</person-group><article-title>Preparing previously COVID-19-positive patients for elective surgery: A framework for preoperative evaluation</article-title><source>Perioper Med</source><year>2021</year><volume>10</volume><fpage>2</fpage><lpage>5</lpage></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Bauer</surname><given-names>M</given-names></name>
<name><surname>Bernstein</surname><given-names>K</given-names></name>
<name><surname>Dinges</surname><given-names>E</given-names></name>
<name><surname>Delgado</surname><given-names>C</given-names></name>
<name><surname>El-Sharawi</surname><given-names>N</given-names></name>
<name><surname>Sultan</surname><given-names>P</given-names></name>
<etal/>
</person-group><article-title>Obstetric anesthesia during the COVID-19 pandemic</article-title><source>Anesth Analg</source><year>2020</year><volume>13</volume><fpage>7</fpage><lpage>15</lpage></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Gilsanz</surname><given-names>F</given-names></name>
<name><surname>Guasch</surname><given-names>E</given-names></name>
</person-group><article-title>Criteria for admission and discharge from resuscitation in obstetric patients</article-title><source>Update of the care protocols of the Obstetric Anesthesia Section of SEDAR</source><year>2016</year><fpage>233</fpage><lpage>50</lpage></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>YH</given-names></name>
<name><surname>Cai</surname><given-names>L</given-names></name>
<name><surname>Cheng</surname><given-names>ZS</given-names></name>
<name><surname>Cheng</surname><given-names>H</given-names></name>
<name><surname>Deng</surname><given-names>T</given-names></name>
<name><surname>Fan</surname><given-names>YP</given-names></name>
<etal/>
</person-group><article-title>A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)</article-title><source>Mil Med Res</source><year>2020</year><volume>7</volume><fpage>4</fpage><pub-id pub-id-type="pmid">32029004</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Crowhurst</surname><given-names>JA</given-names></name>
</person-group><article-title>Anaesthesia for non-obstetric surgery during pregnancy</article-title><source>Acta Anaesthesiol Belg</source><year>2002</year><volume>53</volume><fpage>295</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12503353</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Goodman</surname><given-names>S</given-names></name>
</person-group><article-title>Anaesthesia for nonobstetric surgery in the pregnant patient</article-title><source>Semin Perinatol</source><year>2002</year><volume>26</volume><fpage>136</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">12005471</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="webpage" publication-format="web"><source>Ministerio de sanidad</source><year>2020</year><comment>Available from: <uri xlink:href="https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Documentomanejoembarazoreciennacido.pdf">https://www.mscbs.gob.es/profesiona les/saludPublica/ccayes/alertasActual/nCov-China/documentos/Documentomanejoembarazoreciennacido.pdf</uri></comment><date-in-citation>Last accessed on 15-12-2021</date-in-citation></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Chen</surname><given-names>R</given-names></name>
<name><surname>Cao</surname><given-names>C</given-names></name>
<name><surname>Gong</surname><given-names>Y</given-names></name>
<name><surname>Zhou</surname><given-names>Q</given-names></name>
<name><surname>Wei</surname><given-names>M</given-names></name>
<etal/>
</person-group><article-title>The risk of neuraxial anesthesia -related hypotension in COVID-19 parturients undergoing cesereandelivery: Amulticenter, retrospective, propensity score matched cohort study</article-title><source>Front Med</source><year>2021</year><volume>8</volume><fpage>713733</fpage></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Shouman</surname><given-names>K</given-names></name>
<name><surname>Vanichachorn</surname><given-names>G</given-names></name>
<name><surname>Cheshire</surname><given-names>WP</given-names></name>
<name><surname>Suarez</surname><given-names>MD</given-names></name>
<name><surname>Shelly</surname><given-names>S</given-names></name>
<name><surname>Lamotte</surname><given-names>GJ</given-names></name>
<etal/>
</person-group><article-title>Autonomic dysfunction following COVID-19 infection: An early experience</article-title><source>Clin Auton Res</source><year>2021</year><volume>31</volume><fpage>385</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">33860871</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Katikar</surname><given-names>MD</given-names></name>
</person-group><article-title>Adrenal insufficiency as a post-COVID-19 sequela</article-title><source>Indian J Anaesth</source><year>2021</year><volume>65</volume><fpage>912</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">35221368</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Pani</surname><given-names>N</given-names></name>
<name><surname>Mishra</surname><given-names>SB</given-names></name>
<name><surname>Rath</surname><given-names>SK</given-names></name>
</person-group><article-title>Diabetic parturient - Anaesthetic implications</article-title><source>Indian J Anaesth</source><year>2010</year><volume>54</volume><fpage>387</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">21189875</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Moghissi</surname><given-names>ES</given-names></name>
<name><surname>Korytkowski</surname><given-names>MT</given-names></name>
<name><surname>Di Nardo</surname><given-names>M</given-names></name>
<name><surname>Einhorn</surname><given-names>D</given-names></name>
<name><surname>Hellman</surname><given-names>R</given-names></name>
<name><surname>Hirsch</surname><given-names>IB</given-names></name>
<etal/>
</person-group><article-title>American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><fpage>1119</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">19429873</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Capes</surname><given-names>SE</given-names></name>
<name><surname>Hunt</surname><given-names>D</given-names></name>
<name><surname>Malmberg</surname><given-names>K</given-names></name>
<name><surname>Gerstein</surname><given-names>HC</given-names></name>
</person-group><article-title>Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview</article-title><source>Lancet</source><year>2000</year><volume>355</volume><fpage>773</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10711923</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Kaur</surname><given-names>B</given-names></name>
<name><surname>Sharma</surname><given-names>LM</given-names></name>
<name><surname>Choudhary</surname><given-names>R</given-names></name>
<name><surname>Sharma</surname><given-names>R</given-names></name>
<name><surname>Gupta</surname><given-names>L</given-names></name>
</person-group><article-title>Comparison of analgesic efficacy of transversus abdominis plane block with local wound infiltration using 0.25% levobupivacaine for post cesarean analgesia: A randomized controlled trial</article-title><source>Indian J Clin Anaesth</source><year>2021</year><volume>8</volume><fpage>567</fpage><lpage>73</lpage></element-citation></ref></ref-list></back></article>
